See what you missed at ASRM 2024 with the ASRM 2024 Recorded Bundle
Human embryonic aneuploidy may represent one of the final frontiers in assisted reproductive technology, primarily secondary to oocyte aneuploidy. Mammalian oocytes possess unique characteristics
To compare in vitro fertilization treatment outcomes for the oral gonadotropin-releasing hormone (GnRH) antagonist elagolix (E) to the conventionally used injectable GnRH antagonist ganirelix (G)
On behalf of our coinvestigators, we write to respond to concerns raised about the presentation of data published alongside our article, “High rate of isolated teratospermia in a population of
To investigate whether artificial removal of zona pellucida (ZP) at the pronuclear stage improves good-quality embryos and blastocyst development in patients with difficulty conceiving because of
To use murine avatars for studying human endometriotic lesion response to 2 different hormonal regimens to determine whether progesterone receptor (PR) can prospectively predict response to
To investigate whether idiopathic nonobstructive azoospermia (iNOA) has its own transcriptomic signature.
Polycystic ovary syndrome (PCOS) may very well be the most misdiagnosed condition in the field of women’s health. In my clinical practice, almost no week goes by without a patient who has blatant
To study the perinatal outcomes of children born from different conception methods: in vitro fertilization (IVF) with autologous oocytes or IVF with donor egg versus those conceived without
To determine the serum antimüllerian hormone (AMH) and antral follicle count (AFC) thresholds indicating an increased risk of hyperresponse to ovarian stimulation (OS) during in vitro
To investigate if blastocysts originating from different follicular cohorts have variable implantation rates, adjusted for oocyte age, morphology and/or ploidy
Displaying 1 to 10 of 1631 records
